Cargando…

Patient Knowledge about Oral Anticoagulation Therapy Assessed during an Intermediate Medication Review in Swiss Community Pharmacies

Background: Therapy with oral anticoagulation (OAC) can be challenging, especially in high risk groups such as chronic patients. Gaps in patient knowledge about OAC are linked to reduced effectiveness and safety of treatment. The objectives of this study were i) to assess OAC knowledge gathered duri...

Descripción completa

Detalles Bibliográficos
Autores principales: Metaxas, Corina, Albert, Valerie, Habegger, Susanne, Messerli, Markus, Hersberger, Kurt E., Arnet, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355591/
https://www.ncbi.nlm.nih.gov/pubmed/32231095
http://dx.doi.org/10.3390/pharmacy8020054
_version_ 1783558311647379456
author Metaxas, Corina
Albert, Valerie
Habegger, Susanne
Messerli, Markus
Hersberger, Kurt E.
Arnet, Isabelle
author_facet Metaxas, Corina
Albert, Valerie
Habegger, Susanne
Messerli, Markus
Hersberger, Kurt E.
Arnet, Isabelle
author_sort Metaxas, Corina
collection PubMed
description Background: Therapy with oral anticoagulation (OAC) can be challenging, especially in high risk groups such as chronic patients. Gaps in patient knowledge about OAC are linked to reduced effectiveness and safety of treatment. The objectives of this study were i) to assess OAC knowledge gathered during an intermediate medication review (MR) in patients taking vitamin K antagonists (VKA) or non-vitamin K antagonist oral anticoagulants (NOAC); ii) to assess OAC knowledge two weeks after the MR, and iii) to evaluate patient satisfaction with the MR service in community pharmacies. Methods: Chronic OAC patients were invited for a regular MR service in Swiss community pharmacies, the so-called “Polymedication-Check” (PMC). OAC knowledge was assessed with seven newly generated items asked face-to-face during a PMC and by telephone two weeks later. Knowledge gaps, pharmacists’ spontaneous interventions, and patient satisfaction were documented by observing pharmacy students. Treatment groups were compared. Results: Of all patients (n = 81), the number of patients with one or more knowledge gaps decreased from 66% to 31.3% after PMC (p < 0.001). NOAC patients (n = 31) had more knowledge gaps than VKA patients (n = 50; p < 0.05). Most patients (98.6%) were satisfied with the counselling provided by the pharmacists. Conclusion: The majority of chronic OAC patients shows knowledge gaps. Although spontaneous, the provision of tailored education during a PMC increased patient OAC knowledge.
format Online
Article
Text
id pubmed-7355591
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-73555912020-07-23 Patient Knowledge about Oral Anticoagulation Therapy Assessed during an Intermediate Medication Review in Swiss Community Pharmacies Metaxas, Corina Albert, Valerie Habegger, Susanne Messerli, Markus Hersberger, Kurt E. Arnet, Isabelle Pharmacy (Basel) Article Background: Therapy with oral anticoagulation (OAC) can be challenging, especially in high risk groups such as chronic patients. Gaps in patient knowledge about OAC are linked to reduced effectiveness and safety of treatment. The objectives of this study were i) to assess OAC knowledge gathered during an intermediate medication review (MR) in patients taking vitamin K antagonists (VKA) or non-vitamin K antagonist oral anticoagulants (NOAC); ii) to assess OAC knowledge two weeks after the MR, and iii) to evaluate patient satisfaction with the MR service in community pharmacies. Methods: Chronic OAC patients were invited for a regular MR service in Swiss community pharmacies, the so-called “Polymedication-Check” (PMC). OAC knowledge was assessed with seven newly generated items asked face-to-face during a PMC and by telephone two weeks later. Knowledge gaps, pharmacists’ spontaneous interventions, and patient satisfaction were documented by observing pharmacy students. Treatment groups were compared. Results: Of all patients (n = 81), the number of patients with one or more knowledge gaps decreased from 66% to 31.3% after PMC (p < 0.001). NOAC patients (n = 31) had more knowledge gaps than VKA patients (n = 50; p < 0.05). Most patients (98.6%) were satisfied with the counselling provided by the pharmacists. Conclusion: The majority of chronic OAC patients shows knowledge gaps. Although spontaneous, the provision of tailored education during a PMC increased patient OAC knowledge. MDPI 2020-03-28 /pmc/articles/PMC7355591/ /pubmed/32231095 http://dx.doi.org/10.3390/pharmacy8020054 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Metaxas, Corina
Albert, Valerie
Habegger, Susanne
Messerli, Markus
Hersberger, Kurt E.
Arnet, Isabelle
Patient Knowledge about Oral Anticoagulation Therapy Assessed during an Intermediate Medication Review in Swiss Community Pharmacies
title Patient Knowledge about Oral Anticoagulation Therapy Assessed during an Intermediate Medication Review in Swiss Community Pharmacies
title_full Patient Knowledge about Oral Anticoagulation Therapy Assessed during an Intermediate Medication Review in Swiss Community Pharmacies
title_fullStr Patient Knowledge about Oral Anticoagulation Therapy Assessed during an Intermediate Medication Review in Swiss Community Pharmacies
title_full_unstemmed Patient Knowledge about Oral Anticoagulation Therapy Assessed during an Intermediate Medication Review in Swiss Community Pharmacies
title_short Patient Knowledge about Oral Anticoagulation Therapy Assessed during an Intermediate Medication Review in Swiss Community Pharmacies
title_sort patient knowledge about oral anticoagulation therapy assessed during an intermediate medication review in swiss community pharmacies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355591/
https://www.ncbi.nlm.nih.gov/pubmed/32231095
http://dx.doi.org/10.3390/pharmacy8020054
work_keys_str_mv AT metaxascorina patientknowledgeaboutoralanticoagulationtherapyassessedduringanintermediatemedicationreviewinswisscommunitypharmacies
AT albertvalerie patientknowledgeaboutoralanticoagulationtherapyassessedduringanintermediatemedicationreviewinswisscommunitypharmacies
AT habeggersusanne patientknowledgeaboutoralanticoagulationtherapyassessedduringanintermediatemedicationreviewinswisscommunitypharmacies
AT messerlimarkus patientknowledgeaboutoralanticoagulationtherapyassessedduringanintermediatemedicationreviewinswisscommunitypharmacies
AT hersbergerkurte patientknowledgeaboutoralanticoagulationtherapyassessedduringanintermediatemedicationreviewinswisscommunitypharmacies
AT arnetisabelle patientknowledgeaboutoralanticoagulationtherapyassessedduringanintermediatemedicationreviewinswisscommunitypharmacies